
Dermatologist / dermatopathologist-scientist, translational skin cancer researcher, @MoffittNews, Father, Husband
Tampa, Florida, USA
Joined February 2020
- Tweets4.4K
- Following827
- Followers801
- Likes8.4K
Kenneth Y. Tsai retweeted
Check out our latest uveal melanoma paper: Allele‐Specific GNAQ Q209 Mutations Reveal Context‐Dependent Oncogenic Programs in Uveal Melanoma - Pigment Cell & Melanoma Research - Wiley Online Library onlinelibrary.wiley.com/doi/…
Kenneth Y. Tsai retweeted
Tune in from #ESMO2026 with @DrKhushalani 👇
.@DrKushalani, of @MoffittNews, previews the primary analysis of the randomized phase 3 HBI-8000-303 trial, evaluating nivolumab plus HBI-8000 or placebo in advanced melanoma #melsm #ESMO26 @myESMO
Kenneth Y. Tsai retweeted
At #ESMO26 Peter Forsyth, MD (@PeterForsyth27) shares promising results from new research on leptomeningeal disease in women with breast cancer. Phase 1 results show intrathecal dendritic cell therapy was well tolerated, with encouraging immune activity, paving the way for further study. #MoffittESMO26
Kenneth Y. Tsai retweeted
Some pics from the event. What an amazing time. Thank you @OlofssonBagge from the bottom of my heart. It was a perfect evening
I am incredibly humbled to receive such an amazing honor from @OlofssonBagge and @SahlgrenskaAcad @goteborgsuni with an Honorary Doctorate in medicine. Ceremony is tomorrow. @MoffittNews more pics to come!!
Kenneth Y. Tsai retweeted
Full story here: city-journal.org/article/gow…
An answer to all the NIMBYs who insist that development helps only the rich, and anything with views and natural light is inherently suspicious.
Kenneth Y. Tsai retweeted
Yes, I live in Gowanus, by choice. @NYMag can spread evidence-free claims about toxic waste, but the new buildings here are a vast improvement from the substandard housing many New Yorkers are forced into. Here's the view from my terrace. Link to my @CityJournal story in reply.
Kenneth Y. Tsai retweeted
Could a new combination therapy improve outcomes for patients with advanced melanoma?
At #ESMO26, Nikhil Khushalani, MD (@DrKhushalani), shares encouraging results from a global phase 3 trial evaluating HBI-8000 plus nivolumab, which could help establish a new standard of care. #MoffittESMO26
Kenneth Y. Tsai retweeted
Beyond excited to recruit @VivekSubbiah to @nyulangone @Perlmutter_CC as the new director of our Early Phase Drug Development Program and the Rare Cancer Program.
Congratulate Vivek when you see him at #ESMO26. Welcome to NYC!
@JohnPLeonardMD
nyulangone.org/news/perlmutt…
Kenneth Y. Tsai retweeted
I am incredibly humbled to receive such an amazing honor from @OlofssonBagge and @SahlgrenskaAcad @goteborgsuni with an Honorary Doctorate in medicine. Ceremony is tomorrow. @MoffittNews more pics to come!!
Kenneth Y. Tsai retweeted
Can enfortumab vedotin plus pembrolizumab improve event-free survival in muscle-invasive bladder cancer?
Join Jonathan Chatzkel, MD, at #ESMO26 tomorrow, where he shares exploratory analyses from the KEYNOTE-B15/EV-304 trial. #MoffittESMO26

ALT This image is a promotional graphic for an event at ESMO 2026. It features Jonathan Chatzkel, MD, discussing a Phase 3 clinical trial (KEYNOTE-B15) related to bladder cancer treatments. The event details include the date and time, Fri, Oct. 23, 1:30 to 3:00 p.m. CEST, and location, Bilboa Auditorium - Hall 3. Logos for ESMO 2026 and Moffitt Cancer Center are present.
Kenneth Y. Tsai retweeted
Could localized therapies control aggressive skin cancers while minimizing toxicity throughout the body?
At #BMES2026, Colleen Sheehan shares research on nanoparticle-based topical drug delivery. #MoffittBMES26
Kenneth Y. Tsai retweeted
One of the most meaningful parts of my listening tours is spending time with the people who make Moffitt’s mission possible every day. Our Planning, Design and Construction team has helped carry us through a period of tremendous growth, bringing our vision to life and building the spaces where hope, discovery and healing happen. I’m grateful for their dedication, partnership and all they do to move @MoffittNews forward!
Kenneth Y. Tsai retweeted
Congratulations Jane Messina, MD!
Congratulations to this year's winners of the @USFHealthMed Distinguished Physician Alumni Awards:
- Academics: Jane Messina, MD '88, #MCOM professor, a renowned dermatopathologist working at @MoffittNews to prevent, treat and cure melanoma
- Service: Valerie Riddle, MD '89, former chair of our Alumni Society Board and former associate dean for Alumni Engagement as well as a wonderful educator and volunteer physician for our BRIDGE Healthcare Clinic
- Early Career Achievement: Jennifer R. Chevinsky, MD '16, MPH, just 10 years out of med school and already the Public Health Officer in Riverside County, CA, overseeing public health services for more than 2.5 million residents in one of the nation’s largest and fastest-growing counties.
Kenneth Y. Tsai retweeted
#ESMO26 Abstracts – Among ours | #Realworld stage III #melanoma outcomes following #neoadjuvant #nivolumab + #relatlimab or #nivolumab + #ipilimumab | To be presented by Mike Postow on behalf of this outstanding team in #Madrid #Spain | @MoffittNews
cslide.ctimeetingtech.com/es…
Kenneth Y. Tsai retweeted
We had a great time at #montagna_symposium. Fun to discuss the biology of tissue resident memory cells with friends and colleagues. @ThomasKupper3 @liveidsmo @KaplanLab @HarrisTryonLab @HarrisVitiligo @CaImmunoprevent
Kenneth Y. Tsai retweeted
It was an honor to present at The Robert L. Comis, MD Translational Science Symposium on the role that inflammation plays in tumorigenesis with the aim to find targets for cancer prevention and interception. Thanks ECOG-ACRIN cancer research group for this incredible opportunity.
The Robert L. Comis, MD #TranslationalScience Symposium has begun with great talks on "#Inflammation as a Shared Mechanism Across Diseases" by @MoghaddamSeyed & @humam_kadara of @UTMDAnderson & @tonyrcillo of @UPMCHillmanCC #eaonc
Kenneth Y. Tsai retweeted
#ESMO26 Abstracts – Among ours | A surveillance, epidemiology & end results (#SEER) #Medicare analysis of outcomes & treatment patterns in #nonmetastatic #melanoma | Presenting this week in #Madrid #Spain on behalf of this outstanding team @MoffittNews
cslide.ctimeetingtech.com/es…
Kenneth Y. Tsai retweeted
Am excited to have the opportunity to host Melita Irving from the University of Lausanne. She is a talented immune engineer. Looking forward to her talk.
🧬 How can we make T-cell therapies safer and more effective against solid tumors?
Looking forward to hearing from Melita Irving, PhD (University of Lausanne), at Thursday’s internal Hamon Center/Simmons virtual lecture!
#CellTherapy #Immunotherapy
Kenneth Y. Tsai retweeted
“In a reanalysis of published data and in an independent cohort, after adjustment for multiple confounders, SARS-CoV-2 mRNA vaccination did not improve immunotherapy-related survival in patients with cancer.”
“Together, these findings indicate that the previously reported vaccination survival advantage is largely explained by selection bias, with patients who had more favorable prognoses more likely to receive the SARS-CoV-2 vaccination, particularly in the early pandemic.”
aacrjournals.org/cancerdisco…
@weldeiry @RobertKennedyJr @VPrasadMDMPH @NIHDirector_Jay @jsm2334
Kenneth Y. Tsai retweeted
Thank you to @OSInstitute and @TheMarkFdn for the invitation this weekend at the IO summit for #osteosarcoma. Tremendous opportunity to identify opportunities for collaboration. I learned so much from you all. @PatrickHwuMD








































